0000886163-22-000103.txt : 20220630 0000886163-22-000103.hdr.sgml : 20220630 20220630183237 ACCESSION NUMBER: 0000886163-22-000103 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220629 FILED AS OF DATE: 20220630 DATE AS OF CHANGE: 20220630 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Haas Jason CENTRAL INDEX KEY: 0001883821 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33093 FILM NUMBER: 221059074 MAIL ADDRESS: STREET 1: C/O SYROS PHARMACEUTICALS, INC. STREET 2: 35 CAMBRIDGEPARK DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02140 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LIGAND PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000886163 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770160744 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3911 SORRENTO VALLEY BLVD STREET 2: SUITE 110 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-550-7500 MAIL ADDRESS: STREET 1: 3911 SORRENTO VALLEY BLVD STREET 2: SUITE 110 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2022-06-29 0 0000886163 LIGAND PHARMACEUTICALS INC LGND 0001883821 Haas Jason 5980 HORTON STREET, SUITE 405 EMERYVILLE CA 94608 1 0 0 0 Common Stock 2022-06-29 4 A 0 1750 0.0 A 1750 D Non-Qualified Stock Option (right to buy) 88.48 2022-06-29 4 A 0 5907 0.0 A 2032-06-29 Common Stock 5907 5907 D The option becomes exercisable in 3 successive annual installments upon completion of each calendar year of service beginning on the grant date. By: Charles S. Berkman For: Jason Haas 2022-06-30